Sulzer Orthopedics' Natural-Knee system approved for cementless applications:
This article was originally published in Clinica
Sulzer Orthopedics, a subsidiary of Sulzer Medica, has received FDA approval of its Natural-Knee Primary system for cementless applications. Younger and more active patients who require knee replacement surgery are expected to be the primary beneficiaries of the product.
You may also be interested in...
Financial ties between companies and healthcare bodies distort the production and use of evidence, claims a paper co-authored by researchers, clinicians and decision makers, including a representative of Germany’s HTA body, IQWiG.
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.